Skip to content

Drug interactions

Hydrochlorothiazide-olmesartan + Sofosbuvir / velpatasvir

Severity: Minor

Hydrochlorothiazide-olmesartan and Sofosbuvir / velpatasvir: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Velpatasvir inhibits hepatic and intestinal OATP transporters, and olmesartan is an OATP1B1/1B3 substrate. Olmesartan exposure may rise modestly, increasing the potential for hypotension or renal effects.

What this interaction means in plain words

Hydrochlorothiazide-olmesartan and Sofosbuvir / velpatasvir have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Evidence level: Low

Why it happens

Velpatasvir inhibition of OATP1B1, OATP1B3 and OATP2B1 reduces olmesartan uptake and clearance.

What to do

No empiric dose change is needed. Monitor blood pressure and renal function when starting or stopping therapy.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Hydrochlorothiazide-olmesartan and Sofosbuvir / velpatasvir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Hydrochlorothiazide-olmesartan with Sofosbuvir / velpatasvir?

MediHelp rates the interaction as minor. Hydrochlorothiazide-olmesartan and Sofosbuvir / velpatasvir have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Velpatasvir inhibits hepatic and intestinal OATP transporters, and olmesartan is an OATP1B1/1B3 substrate. Olmesartan exposure may rise modestly, increasing the potential for hypotension or renal effects.

How serious is the interaction between Hydrochlorothiazide-olmesartan and Sofosbuvir / velpatasvir?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No empiric dose change is needed. Monitor blood pressure and renal function when starting or stopping therapy.

What other medicines interact with Hydrochlorothiazide-olmesartan?

MediHelp also lists interactions of Hydrochlorothiazide-olmesartan with, for example, Aliskiren, Dofetilide, Sparsentan. The full list is on the Hydrochlorothiazide-olmesartan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in